Overcoming Graft Rejection in Induced Pluripotent Stem Cell-Derived Inhibitory Interneurons for Drug-Resistant Epilepsy
Background: Cell-based therapies for drug-resistant epilepsy using induced pluripotent stem cell-derived inhibitory interneurons are now in early-phase clinical trials, building on findings from trials in Parkinson’s disease (PD) and Huntington’s disease (HD). Graft rejection and the need for immuno...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-10-01
|
| シリーズ: | Brain Sciences |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2076-3425/14/10/1027 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
